Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapy
Banna, G. L., Di Quattro, R., Malatino, L., Fornarini, G., Addeo, A., Maruzzo, M., Urzia, V., Rundo, F., Lipari, H., De Giorgi, U., Basso, U.
Published in Clinical & translational oncology (01.11.2020)
Published in Clinical & translational oncology (01.11.2020)
Get full text
Journal Article
1655P Association of location of BRCA1/2 pathogenic variants with benefit from PARP-inhibitors in metastatic castration-resistant prostate cancers: Results from the PROGRESS study
Incorvaia, L., Maruzzo, M., Basso, U., Antonuzzo, L., Rizzo, M., Conteduca, V., Messina, C., Bracarda, S., Mammone, G., Scagliarini, S., Maiorano, B.A., Santoni, M., Facchini, G., Lipari, H., Formisano, L., Malapelle, U., Bazan Russo, T.D., Puglisi, M., Bazan, V., Russo, A.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1895P Time to treatment failure (TTF) and treatment beyond progression (TBP) in pretreated metastatic renal cell carcinoma (mRCC) patients (pts) receiving nivolumab: A survival outcome and a therapeutic strategy of clinical benefit (meet-uro 15)
Rebuzzi, S.E., Signori, A., Buti, S., Maruzzo, M., De Giorgi, U.F.F., Zucali, P.A., Procopio, G., Fratino, L., Pipitone, S., Mollica, V., Soraru, M., Chiellino, S., Lipari, H., Galli, L., Masini, C., Naglieri, E., Milella, M., Ricotta, R., Banna, G.L., Fornarini, G.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Predictive and prognostic value of early pet evaluation on disease progression of advanced non-small cell lung cancer
Banna, G.L., Anile, G., Russo, G., Vigneri, P., Castaing, M., Nicolosi, M., Strano, S., Fraggetta, F., Marletta, F., Gieri, S., Spina, S., Scandurra, G., Calì, S., Lipari, H., Ippolito, M.
Published in Annals of oncology (01.10.2015)
Published in Annals of oncology (01.10.2015)
Get full text
Journal Article
Induction chemotherapy with gemcitabine-carboplatin-paclitaxel (GEMCAP) in stage III non-small cell lung cancer (NSCLC)
Banna, G. L., Lipari, H., Buscarino, C., Seca, A., Basile, A., Ippolito, M., Novello, G., Condorelli, R., Cavallaro, S., Squadrito, G., D'Arrigo, M., Gebbia, V., Terminella, A., Saita, S.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
First-line bevacizumab (B) plus paclitaxel (P) in HER2-negative (HER2-ve) metastatic breast cancer (mBC): Efficacy and safety in an Italian multicenter retrospective study
Andreis, D., Scandurra, G., Santini, D., Gucciardino, C., La Verde, N. M., Girelli, S., Alabiso, I., Saetta, A., Atzori, F., Collovà, E., Ferzi, A., Gori, S., Lipari, H., Saggia, C., Marcon, I., Generali, D. G.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article